ARTA
CSCI

A.R.T. Advisors’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

A.R.T. Advisors’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-114
Closed -$19K – 1712
2018
Q3 		$19K Buy
+114
New +$20.9K ﹤0.01% 1350
2017
Q3 		– Sell
-522
Closed -$52K – 1718
2017
Q2 		$52K Buy
+522
New +$82.7K ﹤0.01% 1301

Other funds holding CSCI

JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

A.R.T. Advisors's CSCI Position: Q4 2018 in Review

A.R.T. Advisors sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2018, closing a stake of 114 shares — an estimated $19K sold.

A.R.T. Advisors first reported a position in CSCI in Q2 2017 and held it in 2 quarters. The position peaked at $52K in Q2 2017. 24 funds tracked by Wall St. Rank hold CSCI as of Q4 2018.

  • A.R.T. Advisors reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 114 COSCIENS Biopharma Inc. Common Stock shares in Q4 2018, an estimated $19K.
  • A.R.T. Advisors first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • A.R.T. Advisors's COSCIENS Biopharma Inc. Common Stock position peaked at $52K in Q2 2017.
  • 24 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.